PHAXIAM Therapeutics SA (PHXM) Cash From Operations

Annual CFO

-$33.50 M
+$33.67 M+50.13%

December 31, 2022

Summary

Performance

1-Year Change

+50.13%

3-Year Change

+30.91%

5-Year Change

-19.74%

15-Year Change

-19.74%

PHXM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$798.90 K
PHXM annual cash flow from operations is currently -4293.04% below its historical high of $798.90 thousand

3-Year Low

-$67.17 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
PHXM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
PHXM next annual earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Annual CFI

$40.21 M
PHXM annual cash flow from investing activities is $40.21 million

Annual CFF

-$1.86 M
PHXM annual cash flow from financing activities is -$1.86 million

Annual FCF

-$33.59 M
PHXM annual free cash flow is -$33.59 million

Annual CAPEX

-
PHXM annual capital expenditures value is unknown

Quarterly CFO

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$22.04 M
PHXM quarterly cash flow from operations is currently at an all-time high

3-Year Low

-$22.04 M
PHXM quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Quarterly CFI

-
PHXM quarterly cash flow from investing activities value is unknown

Quarterly CFF

-
PHXM quarterly cash flow from financing activities value is unknown

Quarterly FCF

-
PHXM quarterly free cash flow value is unknown

Quarterly CAPEX

-
PHXM quarterly capital expenditures value is unknown

TTM CFO

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$22.04 M
PHXM TTM cash flow from operations is currently at an all-time high

3-Year Low

-$22.04 M
PHXM TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

TTM CFI

-
PHXM TTM cash flow from investing activities value is unknown

TTM CFF

-
PHXM TTM cash flow from financing activities value is unknown

TTM FCF

-
PHXM TTM free cash flow value is unknown

TTM CAPEX

-
PHXM TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PHXM Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+50.1%--
3 y3 years+30.9%--
5 y5 years-19.7%--

PHXM Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.5%
5 y5-yearat high+100.5%
alltimeall time-4293.0%+100.5%

PHAXIAM Therapeutics SA Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2022
-$33.50 M(-50.1%)
-
-
Jun 2022
-
-$22.04 M(-43.9%)
-$22.04 M(-43.9%)
Dec 2021
-$67.17 M(+13.7%)
-
-
Jun 2021
-
-$39.30 M(+22.0%)
-$39.30 M(-46.2%)
Dec 2020
-$59.07 M(+21.8%)
-
-
Jun 2020
-
-$32.21 M(-21.0%)
-$72.99 M(+8.1%)
Dec 2019
-$48.49 M
-
-
Sep 2019
-
-$40.78 M(+52.4%)
-$67.54 M(-5.2%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$26.76 M(-39.9%)
-$71.25 M(+60.1%)
Dec 2018
-$56.51 M(+102.0%)
-
-
Sep 2018
-
-$44.50 M
-$44.50 M
Dec 2017
-$27.98 M(+43.5%)
-
-
Dec 2016
-$19.49 M(+20.5%)
-
-
Dec 2015
-$16.18 M(+67.9%)
-
-
Dec 2014
-$9.64 M(+12.1%)
-
-
Dec 2013
-$8.60 M(-1176.1%)
-
-
Dec 2012
$798.90 K
-
-

FAQ

  • What is PHAXIAM Therapeutics SA annual cash flow from operations?
  • What is the all time high annual CFO for PHAXIAM Therapeutics SA?
  • What is PHAXIAM Therapeutics SA annual CFO year-on-year change?
  • What is the all time high quarterly CFO for PHAXIAM Therapeutics SA?
  • What is the all time high TTM CFO for PHAXIAM Therapeutics SA?

What is PHAXIAM Therapeutics SA annual cash flow from operations?

The current annual CFO of PHXM is -$33.50 M

What is the all time high annual CFO for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high annual cash flow from operations is $798.90 K

What is PHAXIAM Therapeutics SA annual CFO year-on-year change?

Over the past year, PHXM annual cash flow from operations has changed by +$33.67 M (+50.13%)

What is the all time high quarterly CFO for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high quarterly cash flow from operations is -$22.04 M

What is the all time high TTM CFO for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high TTM cash flow from operations is -$22.04 M